HCPCS drug code · CMS crosswalk
Nelarabine J-Code / HCPCS Code
In short
Nelarabine is billed under HCPCS J9261 — Injection, nelarabine, 50 mg. One billing unit is 50 mg. CMS's crosswalk lists 18 Nelarabine NDCs under this code.
Reference
- J9261
- Injection, nelarabine, 50 mgBilling unit: 50 mg
- Labelers
- Alembic Pharmaceuticals Inc.; Amneal Pharmaceuticals, LLC; Dr. Reddy's Laboratories Inc.; Meitheal Pharmaceuticals Inc.; Novadoz Pharmaceuticals LLC; Sagent Pharmaceuticals; Shorla Oncology Inc.; XGen Pharmaceuticals DJB, Inc.and 1 more
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Nelarabine units and claim line
Enter the dose given to get the J9261 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Nelarabine NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 25021-0259-50 | J9261 | Sagent Pharmaceuticals | 50 | 5 |
| 25021-0259-51 | J9261 | Sagent Pharmaceuticals | 6 × 50 | 30 |
| 39822-0650-01 | J9261 | XGen Pharmaceuticals DJB, Inc. | 50 | 5 |
| 39822-0650-06 | J9261 | XGen Pharmaceuticals DJB, Inc. | 6 × 50 | 30 |
| 43598-0142-06 | J9261 | Dr. Reddy's Laboratories Inc. | 6 × 50 | 30 |
| 43598-0142-11 | J9261 | Dr. Reddy's Laboratories Inc. | 50 | 5 |
| 62332-0813-50 | J9261 | Alembic Pharmaceuticals Inc. | 50 | 5 |
| 70121-1743-04 | J9261 | Amneal Pharmaceuticals, LLC | 6 × 50 | 30 |
| 70710-1726-01 | J9261 | Zydus Pharmaceuticals (USA) Inc. | 50 | 5 |
| 70710-1726-08 | J9261 | Zydus Pharmaceuticals (USA) Inc. | 6 × 50 | 30 |
| 70710-1839-01 | J9261 | Zydus Pharmaceuticals (USA) Inc. | 50 | 5 |
| 70710-1839-08 | J9261 | Zydus Pharmaceuticals (USA) Inc. | 6 × 50 | 30 |
| 71288-0165-53 | J9261 | Meitheal Pharmaceuticals Inc. | 6 × 50 | 30 |
| 71288-0165-54 | J9261 | Meitheal Pharmaceuticals Inc. | 50 | 5 |
| 72205-0154-01 | J9261 | Novadoz Pharmaceuticals LLC | 50 | 5 |
| 72205-0154-04 | J9261 | Novadoz Pharmaceuticals LLC | 6 × 50 | 30 |
| 81927-0111-01 | J9261 | Shorla Oncology Inc. | 50 | 5 |
| 81927-0111-06 | J9261 | Shorla Oncology Inc. | 6 × 50 | 30 |
Nelarabine: common questions
- What is the J-code for Nelarabine?
- Nelarabine is billed under HCPCS J9261 — Injection, nelarabine, 50 mg. One billing unit is 50 mg. CMS's crosswalk lists 18 Nelarabine NDCs under this code.
- How many J9261 billing units are in a package of Nelarabine?
- CMS lists 5 to 30 billing units per package, depending on the NDC, where one unit is 50 mg. Units to report are based on the dose given, not the package.
- Is J9261 a CPT code?
- No. J9261 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.